“Ustekinumab treats psoriasis by suppressing RORC and T-box but its suppression of GATA restrains its efficacy” (2018) Brazilian Journal of Pharmaceutical Sciences, 54(4), p. e17349. doi:10.1590/s2175-97902018000417349.